Werner Stilmant Named General Manager of ProductLife Group Belgium and Germany
Life sciences outsourcing and consulting services specialist ProductLife Group (PLG) has announced another strategic senior management appointment as part of its continued international growth plans. Werner Stilmant has joined the group as General Manager of ProductLife Group Belgium and Germany.
Werner brings broad experience to the role, from his years in clinical research, business process management, outsourcing and consulting. He started out in the life sciences industry as a clinical researcher before moving into the distribution and supply chain side of the business. In each of his managerial roles to date, Werner has applied his knowledge of lean concepts to improving and streamlining business processes.
His experience in leading both small and large groups gives him the flexibility and people management skills needed to manage PLG’s diverse and highly skilled teams in Belgium and Germany, according to Adam Sherlock, the group’s CEO. Werner will draw on his experiences within pharma, contract research organisations (CROs), and as a consultant to help his team optimise their talent pools.
“Werner’s diplomatic and open communication style is well suited to the PLG culture and will serve to underscore our company’s commitment to building new business opportunities, enhancing our market footprint, and further integrating our core regulatory, pharmacovigilance, and quality capabilities. He is a very welcome addition to the senior team,” Adam said.
The appointment of a new general manager for Belgium and Germany is the latest in a series of high-profile leadership changes at PLG — designed to reinforce the top team as the group advances its plans to expand deeper into Europe and to penetrate new markets. Other recent changes have included a separation of the roles of Chairman and CEO.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance